These data indicate that: (a) myeloid cells mediate, at least in part, the Egfl6-induced tumor progression; and (b) granulocytic/monocytic cells play a crucial role in the TAMs phenotype in Egfl6+ tumors. The gene discussed is EGFL6; the disease is neoplasm.